Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
BLTE — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

3.12

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

-0.33

EPS Last/This Y

0.18

EPS This/Next Y

2.92

Price

137.14

Target Price

211.5

Analyst Recom

1

Performance Q

-27.45

Upside

-164.5%

Beta

-1.22

Ticker: BLTE



22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-04-23BLTE164.1N/AN/A0
2026-04-24BLTE161.27N/AN/A0
2026-04-27BLTE164.03N/AN/A0
2026-04-28BLTE159.33N/AN/A0
2026-04-29BLTE154.71N/AN/A0
2026-04-30BLTE159.61N/AN/A0
2026-05-01BLTE155.53N/AN/A0
2026-05-04BLTE154.93N/AN/A0
2026-05-05BLTE154.15N/AN/A0
2026-05-06BLTE156.27N/AN/A0
2026-05-07BLTE156.34N/AN/A0
2026-05-08BLTE155.74N/AN/A0
2026-05-11BLTE152.25N/AN/A0
2026-05-12BLTE156.54N/AN/A0
2026-05-13BLTE153.81N/AN/A0
2026-05-14BLTE149.98N/AN/A0
2026-05-15BLTE142.49N/AN/A0
2026-05-18BLTE142.32N/AN/A0
2026-05-19BLTE139.24N/AN/A0
2026-05-20BLTE143.51N/AN/A0
2026-05-21BLTE143.92N/AN/A0
2026-05-22BLTE137.3N/AN/A0
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1



22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-04-23BLTE164.27-42.9- -2.13
2026-04-24BLTE161.20-42.9- -2.13
2026-04-27BLTE163.62-42.9- -2.13
2026-04-28BLTE159.05-42.9- -2.13
2026-04-29BLTE154.66-42.9- -2.13
2026-04-30BLTE159.24-42.9- -2.13
2026-05-01BLTE154.85-42.9- -2.13
2026-05-04BLTE154.76-42.9- -2.13
2026-05-05BLTE154.16-42.9- -2.13
2026-05-06BLTE156.35-42.9- -2.13
2026-05-07BLTE156.00-42.9- -2.13
2026-05-08BLTE155.35-42.9- -2.13
2026-05-11BLTE152.50-42.9- -2.13
2026-05-12BLTE156.16-42.9- -2.13
2026-05-13BLTE153.89-42.9- -2.13
2026-05-14BLTE150.27-42.9- -2.13
2026-05-15BLTE142.38-42.9- -2.13
2026-05-18BLTE142.82-42.9- -2.13
2026-05-19BLTE139.52-42.9- -2.13
2026-05-20BLTE143.68-42.9- -2.13
2026-05-21BLTE143.92-42.9- -2.13
2026-05-22BLTE137.14-42.9- -2.13
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1



22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-04-23BLTE-5.895.782.64
2026-04-24BLTE-6.405.782.64
2026-04-27BLTE-6.655.732.81
2026-04-28BLTE-6.915.732.81
2026-04-29BLTE-7.165.732.81
2026-04-30BLTE-7.415.732.81
2026-05-01BLTE-7.665.732.81
2026-05-04BLTE-7.905.582.81
2026-05-05BLTE-7.905.582.81
2026-05-06BLTE-8.155.582.81
2026-05-07BLTE-8.395.582.81
2026-05-08BLTE-8.645.582.81
2026-05-11BLTE-8.805.022.81
2026-05-12BLTE-8.805.023.11
2026-05-13BLTE-8.805.023.11
2026-05-14BLTE-8.805.023.11
2026-05-15BLTE-9.405.023.11
2026-05-18BLTE-9.405.133.11
2026-05-19BLTE-9.405.133.11
2026-05-20BLTE-9.405.133.11
2026-05-21BLTE-9.405.133.11
2026-05-22BLTE-9.405.133.12
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS​

-0.34

Avg. EPS Est. Current Quarter

-0.64

Avg. EPS Est. Next Quarter

-0.67

Insider Transactions

-9.4

Institutional Transactions

5.13

Beta

-1.22

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

14

Growth Score

23

Sentiment Score

55

Actual DrawDown %

31.4

Max Drawdown 5-Year %

Target Price

211.5

P/E

Forward P/E

119.65

PEG

P/S

P/B

6.92

P/Free Cash Flow

EPS

-2.53

Average EPS Est. Cur. Y​

-2.13

EPS Next Y. (Est.)

0.79

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.68

Return on Equity vs Sector %

-38.4

Return on Equity vs Industry %

-22.8

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.04

EBIT Estimation

◆ BLTE Healthcare
$137.30
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
16/20
Pullback
13/25
Volume
9/15
Valuation
13/20
TP/AR
2/10
Options
0/10
RSI
31.3
Range 1M
4.8%
🚀
Momentum Growth
Ride accelerating trends
N/A
32 /100
WEAK
Momentum
13/25
Growth
13/30
Estimates
0/20
Inst/Vol
6/15
Options
0/10
EPS Yr
-38.8%
EPS NY
135.8%
52W%
56.5%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🔴 SELL -41.6% upside
Quality
3/30
Valuation
0/30
Growth
9/25
Stability
7/10
LT Trend
1/5
Upside
-41.6%
Quality
14
Click a card to see score breakdown Full Analysis →
Belite Bio, Inc
Sector: Healthcare
Industry: Biotechnology
Employees: 41
Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics with unmet medical needs in the United States. Its lead product candidate is Tinlarebant (LBS-008), an orally administered, which is in phase 3 clinical trial as an early intervention for maintaining the health and integrity of retinal tissues in stargardt disease type 1 and geographic atrophy patients. The company also develops LBS-009, an retinol binding protein 4 oral therapy, which is in preclinical development targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes, as well as gout. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc operates as a subsidiary of Lin Bioscience International Ltd.
BLTE

Latest News

—
Caricamento notizie per BLTE…
stock quote shares BLTE – Belite Bio Inc ADR Stock Price stock today
news today BLTE – Belite Bio Inc ADR stock forecast ,stock prediction 2023 2024 2025
marketwatch BLTE – Belite Bio Inc ADR yahoo finance google finance
stock history BLTE – Belite Bio Inc ADR invest stock market
stock prices BLTE premarket after hours
ticker BLTE fair value insiders trading